Zantac is one of the most common medications on the market for treating heartburn and other similar issues, and has been since the 1980’s. Unfortunately, we have recently discovered that part of the ingredients in Zantac, N-Nitrosodimethylamine (NDMA), can “increases over time and when stored at higher than room temperatures and may result in consumer exposure to unacceptable levels…” The NDMA doesn’t just slightly increase, it can increase between 3,000 and 26,000 times what the FDA approves as safe. This resulted in the FDA requesting that all manufacturers remove all of the Zantac or generic versions of Zantac from the shelves on April 1, 2020.
The increased NDMA can lead to numerous different injuries including:
- Bladder cancer
- Colorectal cancer (colon and rectal cancer)
- Esophageal cancer
- Intestinal cancer
- Kidney cancer
- Liver cancer
- Lung cancer (non-smokers)
- Ovarian cancer
- Pancreatic cancer
- Prostate cancer
- Stomach cancer
- Testicular cancer
- Thyroid cancer
- Uterine cancer
While the lawsuit is commonly referred to as the “Zantac lawsuit” there are numerous other brands or manufacturers who you may have used that would have the same problems including Wal-Zan 150, Wal-Zan 75, Heartburn Relief (ranitidine), Acid Reducer (ranitidine), or Acid Control (ranitidine).
If you used any of those and developed one of the cancers listed above you may qualify to join the Zantac lawsuit. Typically, in order to show that the drug caused cancer a person would need to be taking it pretty consistently for about a year before cancer developed.
Please contact us if you have one of the cancers listed above and took Zantac or a generic version of it. We will be happy to explore your options with you and advise you on what course of action is best for you. We know that many people have no experience with lawsuits like this and we are happy to answer all of your questions.